other material
confidence high
sentiment neutral
materiality 0.15
Marker Therapeutics stockholders approve issuance of 8.28M warrant shares
Marker Therapeutics, Inc.
- At special meeting on March 21, 2025, 4,158,543 shares (38.83% of outstanding) represented.
- Proposal passed: 3,483,897 for, 668,383 against, 6,263 abstained.
- Approves issuance of up to 5,031,250 shares under Series A Warrants and 3,247,445 under Series B Warrants.
- Total authorized warrant shares: 8,278,695, approximately 77% of 10.7M outstanding shares.